Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence

Neuropsychobiology

Volumn 50, Issue 1, 2004, Pages 71-77

  Boeijinga, P H ^a   Parot, P ^b   Soufflet, L ^a   Landron, F ^c   Danel, T ^d   Gendre, I ^a   Muzet, M ^a   Demazieres A ^a   Luthringer, R ^a  

^a FORENAP   (France)

^b Conseil en Pharmacologie Clinique ^*  (France)

^c Merck Sante   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Acamprosate; Alcohol withdrawal; Electroencephalography; Magnetoencephalography

Indexed keywords

ACAMPROSATE; PLACEBO;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALPHA RHYTHM; AROUSAL; ARTICLE; ASTHENIA; BRAIN FUNCTION; BRAIN MAPPING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DYSPEPSIA; HEADACHE; HUMAN; IRRITABILITY; MAGNETOENCEPHALOGRAPHY; MALE; NERVE CELL EXCITABILITY; PARALLEL DESIGN; PARIETAL LOBE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TEMPORAL LOBE; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; AROUSAL; CEREBRAL CORTEX; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; MIDDLE AGED; PLACEBOS; SUBSTANCE WITHDRAWAL SYNDROME; TAURINE;

EID: 2642547224     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077944     Document Type: Article

References (39)

1. Grant KA, Lovinger DM: Cellular and behavioral neurobiology of alcohol: Receptor-mediated neuronal processes. Clin Neurosci 1995;3:155-164.
2. Tsai G, Gastfriend DR, Coyle JT: The glutamatergic basis of human alcoholism. Am J Psychiatry 1995;152:332-340.
3. Lhuintre JP, Daoust M, Moore ND, Chrétien P, Saligaut C, Tran G, Bosimare F, Hillemand B: Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet 1985;i:1014-1016.
4. Paille FM, Guelfi JD, Perkins AC, Royer RJ, Steru L, Parot P: Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol 1995;30:239-247.
5. Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H, Fleischhacker WW: Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 1996;347:1438-1442.
6. Sass H, Soyka M, Mann K, Zieglgansberger W: Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 1996;53:673-680.
7. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT: Pharmacological treatment of alcohol dependence: A review of the evidence. JAMA 1999;281:1318-1325.
8. Mason BJ, Ownby RL: Acamprosate for the treatment of alcohol dependence: A review of double-blind, placebo-controlled trials. CNS Spectr 2000;5:58-69.
9. De Witte P, Dahchour A, Quertemont E: Acute and chronic alcohol injections increase taurine in the nucleus accumbens. Alcohol Alcohol Suppl 1994;2:229-233.
10. Dahchour A, De Witte P: Ethanol and amino acids in the central nervous system: Assessment of the pharmacological actions of acamprosate. Prog Neurobiol 2000;60:343-362.
11. Zeise ML, Kasparov S, Capogna M, Zieglgansberger W: Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: Possible involvement of excitatory amino acid receptors. Eur J Pharmacol 1993;231:47-52.
12. Spanagel R, Putzke J, Stefferl A, Schobitz B, Zieglgansberger W: Acamprosate and alcohol. 2. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 1996;305:45-50.
13. Dahchour A, De Witte P, Bolo N, Nedelec J-F, Muzet M, Durbin P, Macher J-P: Central effects of acamprosate. 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 1998;82:107-114.
14. Dahchour A, Quertemont E, De Witte P: Acute ethanol increases taurine but neither glutamate nor GABA in the nucleus accumbens of male rats: A microdialysis study. Alcohol Alcohol 1994;29:485-487.
15. Naassila M, Hammoumi S, Legrand E, Durbin P, Daoust M: Mechanism of action of acamprosate. 1. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res 1998;22:802-809.
16. Al Qatari M, Bouchenafa O, Littleton J: Mechanism of action of acamprosate. 2. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clin Exp Res 1998;22:810-814.
17. Littleton JM, Lovinger D, Liljequist S, Ticku R, Matsumoto I, Barron S: Role of polyamines and NMDA receptors in ethanol dependence and withdrawal. Alcohol Clin Exp Res 2001;25:132S-136S.
18. Harris BR, Prendergast MA, Gibson DA: Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcohol Clin Exp Res 2002;26:1779-1793.
19. Bolo N, Nedelec JF, Muzet M, De Witte P, Dahchour A, Durbin P, Macher JP: Central effects of acamprosate. 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers. Psychiatry Res 1998;82:115-127.
20. Fourtillan JB: Pharmacokinetics and relative bioavailabilities of acetylhomotaurinate (AOTA) after oral administration of a single dose equal to 666 mg of calcium acetylhomotaurinate (AOTA-Ca) in six young healthy volunteers, when given as aqueous solution and enteric coated tablets. Merck Santé, France, 1989, AD 864 H (data on file).
21. Wilde MI, Wagstaff AJ: Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 1997;53:1038-1053.
22. Hjorth B: An on-line transformation of EEG scalp potentials into orthogonal source derivations. Electroencephalogr Clin Neurophysiol 1975;39:526-530.
23. Matejcek M: Cortical correlates of vigilance regulation and their use in evaluating the effects of treatment. Adv Biochem Psychopharmacol 1980;23:339-348.
24. Matejcek M: Vigilance and the EEG: Psychological, physiological and pharmacological aspects; in Herrmann WM (ed): Electroencephalography in Drug Research. Stuttgart, Fischer, 1982, pp 405-508.
25. Ansseau M, Besson J, Lejoyeux M, Pinto E, Landry U, Cornes M, Deckers F, Potgieter A, Ades J: A French translation of the obsessive-compulsive drinking scale for craving in alcohol-dependent patients: A validation study in Belgium, France, and Switzerland. Eur Addict Res 2000;6:51-56.
26. Spielberger CD, Gorsuch RL, Lushene RE: State-Trait Anxiety Inventory: Test Manual for Form X. Palo Alto, Consulting Psychologists Press, 1970.
27. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM: Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWAAr). Br J Addict 1989;84:1353-1357.
28. Cooley JW, Tuckey JW: An algorithm for the machine calculation of complex Fourier series. Math Comp 1965;19:297-301.
29. Soufflet L, Toussaint M, Luthringer R, Gresser J, Minot R, Macher JP: A statistical evaluation of the main interpolation methods applied to 3-dimensional EEG mapping. Electroencephalogr Clin Neurophysiol 1991;79:393-402.
30. Stancak AJ, Pfurtscheller G: Event-related desynchronisation of central beta-rhythms during brisk and slow self-paced finger movements of dominant and nondominant hand. Cogn Brain Res 1996;4:171-183.
31. Saletu B, Saletu M, Grunberger J, Frey R, Anderer P, Mader R: Treatment of the alcoholic organic brain syndrome: Double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. Neuropsychobiology 1993;27:26-39.
32. Saletu B, Saletu M, Grunberger J, Mader R: Spontaneous and drug-induced remission of alcoholic organic brain syndrome: Clinical, psychometric, and neurophysiological studies. Psychiatry Res 1983;10:59-75.
33. Stenberg G, Sano M, Rosen I, Ingvar DH: EEG topography of acute ethanol effects in resting and activated normals. J Stud Alcohol 1994;55:645-656.
34. Funderburk WH: Electroencephalographic studies in chronic alcoholics. Electroencephalogr Clin Neurophysiol 1949;1:369-370.
35. Gabrielli WF Jr, Mednick SA, Volavka J, Pollock VE, Schulsinger F, Itil TM: Electroencephalograms in children of alcoholic fathers. Psychophysiology 1982;19:404-407.
36. Pollock VE, Volavka J, Goodwin DW, Mednick SA, Gabrielli WF, Knop J, Schulsinger F: The EEG after alcohol administration in men at risk for alcoholism. Arch Gen Psychiatry 1983;40:857-861.
37. Peniston EG, Kulkosky PJ: Alpha-theta brainwave training and beta-endorphin levels in alcoholics. Alcohol Clin Exp Res 1989;13:271-279.
38. Peniston EG, Kulkosky PJ: Alcoholic personality and alpha-theta brainwave training. Med Psychother 1990;3:37-55.
39. Saxby E, Peniston EG: Alpha-theta brainwave neurofeedback training: An effective treatment for male and female alcoholics with depressive symptoms. J Clin Psychol 1995;51:685-693.